Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities
Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...
BioWorld2d
Janssen presents first-in-class bispecific Vδ2 T-cell engaging antibody
The lack of acute myeloid leukemia-specific antigens is one of the challenges for targeted immunotherapy together with on-target off-tumor toxicities due to the expression of the target in normal ...
The Scientist6d
The Art of Microbial Disguise
On the battleground of the human body, microbes use every skill to mask, infiltrate, manipulate, and evade the immune radar.
AZoLifeSciences on MSN6d
Programmable G-protein-coupled receptors redefine therapeutic applications.
This study demonstrates the development of PAGERs (programmable antigen-gated engineered receptors), combining antigen ...